{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T01:51:03Z","timestamp":1789437063319,"version":"build-2803163510"},"reference-count":73,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Revue Neurologique"],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1016\/j.neurol.2008.12.003","type":"journal-article","created":{"date-parts":[[2009,3,6]],"date-time":"2009-03-06T10:19:17Z","timestamp":1236334757000},"page":"373-379","source":"Crossref","is-referenced-by-count":8,"title":["Traitement pharmacologique de l\u2019\u00e9tat de mal r\u00e9fractaire"],"prefix":"10.1016","volume":"165","author":[{"given":"A.O.","family":"Rossetti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Santoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurol.2008.12.003_bib1","first-page":"387","article-title":"Conf\u00e9rence de consensus en r\u00e9animation et m\u00e9decine d\u2019urgence\u00a0: prise en charge de l\u2019\u00e9tat de mal \u00e9pileptique. Soci\u00e9t\u00e9 de r\u00e9animation de langue fran\u00e7aise","volume":"4","author":"Conf\u00e9rence de consensus en r\u00e9animation et m\u00e9decine d\u2019urgence","year":"1995","journal-title":"Rean Urg"},{"key":"10.1016\/j.neurol.2008.12.003_bib2","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1056\/NEJMoa002141","article-title":"A comparison of lorazepam, diazepam and placebo for the treatment of out-of-hospital status epilepticus","volume":"345","author":"Alldredge","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.neurol.2008.12.003_bib3","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1001\/archneur.55.1.119","article-title":"Do nonconvulsive seizures damage the brain?\u2013No","volume":"55","author":"Aminoff","year":"1998","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neurol.2008.12.003_bib4","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/clpt.1985.204","article-title":"Pharmacokinetics of high-dose pentobarbital in severe head trauma","volume":"38","author":"Bayliff","year":"1985","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.neurol.2008.12.003_bib5","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/01.ccx.0000157079.72999.87","article-title":"Refractory status epilepticus","volume":"11","author":"Bleck","year":"2005","journal-title":"Curr Opin Crit Care"},{"key":"10.1016\/j.neurol.2008.12.003_bib6","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0920-1211(00)00175-3","article-title":"Ketamine controls prolonged status epilepticus","volume":"42","author":"Borris","year":"2000","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.neurol.2008.12.003_bib7","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1111\/j.1476-5381.1995.tb15956.x","article-title":"Pentobarbitone modulation of NMDA receptors in neurones isolated from the rat olfactory brain","volume":"116","author":"Charlesworth","year":"1995","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.neurol.2008.12.003_bib8","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S1474-4422(06)70374-X","article-title":"Status epilepticus: pathophysiology and management in adults","volume":"5","author":"Chen","year":"2006","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neurol.2008.12.003_bib9","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1212\/WNL.57.6.1036","article-title":"Continuous EEG monitoring and midazolam infusion for refractory nonconvulsive status epilepticus","volume":"57","author":"Claassen","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2008.12.003_bib10","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1046\/j.1528-1157.2002.28501.x","article-title":"Treatment of refractory status epilepticus with pentobarbital, propofol or midazolam: a systematic review","volume":"43","author":"Claassen","year":"2002","journal-title":"Epilepsia"},{"key":"10.1016\/j.neurol.2008.12.003_bib11","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0022-510X(03)00036-4","article-title":"Treatment of status epilepticus: a survey of neurologists","volume":"211","author":"Claassen","year":"2003","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.neurol.2008.12.003_bib12","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1097\/00000542-199912000-00022","article-title":"Pharmacokinetics of thiopental enantiomers during and following prolonged high-dose therapy","volume":"91","author":"Cordato","year":"1999","journal-title":"Anesthesiology"},{"key":"10.1016\/j.neurol.2008.12.003_bib13","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0140-6736(00)03547-9","article-title":"Long-term propofol infusion and cardiac failure in adult head-injured patients","volume":"357","author":"Cremer","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.neurol.2008.12.003_bib14","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/00004691-199907000-00004","article-title":"Evidence against permanent neurologic damage from nonconvulsive status epilepticus","volume":"16","author":"Drislane","year":"1999","journal-title":"J Clin Neurophysiol"},{"key":"10.1016\/j.neurol.2008.12.003_bib15","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1213\/01.ANE.0000156682.59859.F3","article-title":"Total suppression of cerebral activity by thiopental mimicking propofol infusion syndrome: a fatal common pathway?","volume":"100","author":"Enting","year":"2005","journal-title":"Anesth Analg"},{"key":"10.1016\/j.neurol.2008.12.003_bib16","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1097\/00004691-199512040-00004","article-title":"Pathophysiology of status epilepticus","volume":"12","author":"Fountain","year":"1995","journal-title":"J Clin Neurophysiol"},{"key":"10.1016\/j.neurol.2008.12.003_bib17","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1097\/WCO.0b013e328042bacb","article-title":"The anaesthetic and intensive care of status epilepticus","volume":"20","author":"Holtkamp","year":"2007","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.neurol.2008.12.003_bib18","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1136\/jnnp.74.8.1095","article-title":"The management of refractory generalised convulsive and complex partial status epilepticus in three European countries: a survey among epileptologists and critical care neurologists","volume":"74","author":"Holtkamp","year":"2003","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurol.2008.12.003_bib19","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1001\/archneur.62.9.1428","article-title":"A \u201cmalignant\u201d variant of status epilepticus","volume":"62","author":"Holtkamp","year":"2005","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neurol.2008.12.003_bib20","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1136\/jnnp.2004.041947","article-title":"Predictors and prognosis of refractory status epilepticus treated in a neurological intensive care unit","volume":"76","author":"Holtkamp","year":"2005","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurol.2008.12.003_bib21","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1212\/01.wnl.0000218299.15988.9d","article-title":"Diagnosis of psychogenic nonepileptic status epilepticus in the emergency setting","volume":"66","author":"Holtkamp","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2008.12.003_bib22","series-title":"Status epilepticus. A clinical perspective","first-page":"159","article-title":"Cellular physiology of status epilepticus","author":"Hope","year":"2005"},{"key":"10.1016\/j.neurol.2008.12.003_bib23","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1111\/j.1528-1167.2005.59204.x","article-title":"Calcium-channel blocker verapamil administration in prolonged and refractory status epilepticus","volume":"46","author":"Iannetti","year":"2005","journal-title":"Epilepsia"},{"key":"10.1016\/j.neurol.2008.12.003_bib24","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0006-8993(01)02800-1","article-title":"Propofol and sodium thiopental protect against MK-801-induced neuronal necrosis in the posterior cingulate\/retrosplenial cortex","volume":"913","author":"Jevtovic-Todorovic","year":"2001","journal-title":"Brain Res"},{"key":"10.1016\/j.neurol.2008.12.003_bib25","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1528-1167.2006.00659.x","article-title":"In nonconvulsive status epilepticus (NCSE), treat to burst\u2013suppression: pro and con","volume":"47","author":"Jordan","year":"2006","journal-title":"Epilepsia"},{"key":"10.1016\/j.neurol.2008.12.003_bib26","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0987-7053(00)00238-0","article-title":"No, some types of nonconvulsive status epilepticus cause little permanent neurologic sequelae (or: \u201cthe cure may be worse than the disease\u201d)","volume":"30","author":"Kaplan","year":"2000","journal-title":"Neurophysiol Clin"},{"key":"10.1016\/j.neurol.2008.12.003_bib27","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1136\/jnnp.2007.130260","article-title":"Intravenous levetiracetam in the treatment of benzodiazepine refractory status epilepticus","volume":"79","author":"Knake","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurol.2008.12.003_bib28","first-page":"356","article-title":"Intravenous anesthetics and human neutrophil granulocyte motility in vitro","volume":"36","author":"Kress","year":"1987","journal-title":"Anaesthesist"},{"key":"10.1016\/j.neurol.2008.12.003_bib29","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1111\/j.1528-1157.1996.tb00039.x","article-title":"Relapse and survival after barbiturate anesthetic treatment of refractory status epilepticus","volume":"37","author":"Krishnamurthy","year":"1996","journal-title":"Epilepsia"},{"key":"10.1016\/j.neurol.2008.12.003_bib30","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1111\/j.1528-1157.1999.tb00775.x","article-title":"Depth of EEG suppression and outcome in barbiturate anesthetic treatment for refractory status epilepticus","volume":"40","author":"Krishnamurthy","year":"1999","journal-title":"Epilepsia"},{"key":"10.1016\/j.neurol.2008.12.003_bib31","unstructured":"Leppert D, St\u00f6ckli HR, Fuhr P. Directives pour le traitement de l\u2019\u00e9tat de mal \u00e9pileptique. Schweizerische Aerztezeitung 2005;86. http:\/\/www.saez.ch\/status_epilepticus_f.pdf. (Consult\u00e9 le 16 f\u00e9vrier 2009)."},{"key":"10.1016\/j.neurol.2008.12.003_bib32","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1001\/jama.1983.03330350028021","article-title":"Double-blind study of lorazepam and diazepam in status epilepticus","volume":"249","author":"Leppik","year":"1983","journal-title":"JAMA"},{"key":"10.1016\/j.neurol.2008.12.003_bib33","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1528-1167.2006.00658.x","article-title":"The management of refractory status epilepticus: an update","volume":"47","author":"Lowenstein","year":"2006","journal-title":"Epilepsia"},{"key":"10.1016\/j.neurol.2008.12.003_bib34","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1056\/NEJM199804023381407","article-title":"Status epilepticus","volume":"338","author":"Lowenstein","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.neurol.2008.12.003_bib35","doi-asserted-by":"crossref","first-page":"3639","DOI":"10.2174\/1381612043382846","article-title":"Propofol: therapeutic indications and side-effects","volume":"10","author":"Marik","year":"2004","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.neurol.2008.12.003_bib36","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1001\/archneur.59.2.205","article-title":"Refractory status epilepticus: frequency, risk factors and impact on outcome","volume":"59","author":"Mayer","year":"2002","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neurol.2008.12.003_bib37","first-page":"A379","article-title":"Severely refractory status epilepticus: etiologies and outcomes","volume":"68","author":"Milligan","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2008.12.003_bib38","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1528-1167.2006.00870.x","article-title":"Treatment of status epilepticus in adults: guidelines of the Italian League against Epilepsy","volume":"47","author":"Minicucci","year":"2006","journal-title":"Epilepsia"},{"key":"10.1016\/j.neurol.2008.12.003_bib39","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1001\/archneur.61.8.1254","article-title":"Treatment of refractory status epilepticus with inhalational anesthetic agents isoflurane and desflurane","volume":"61","author":"Mirsattari","year":"2004","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neurol.2008.12.003_bib40","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1212\/WNL.54.6.1366","article-title":"Prolongation of midazolam half-life after sustained infusion for status epilepticus","volume":"54","author":"Naritoku","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2008.12.003_bib41","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1111\/j.1476-5381.1995.tb16660.x","article-title":"Inhibition by propofol (2,6 di-isopropylphenol) of the N-methyl-D-aspartate subtype of glutamate receptor in cultured hippocampal neurones","volume":"116","author":"Orser","year":"1995","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.neurol.2008.12.003_bib42","first-page":"1059","article-title":"Management of adult refractory convulsive status epilepticus in the intensive care unit","volume":"158","author":"Outin","year":"2002","journal-title":"Rev Neurol (Paris)"},{"key":"10.1016\/j.neurol.2008.12.003_bib43","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1136\/bmj.305.6854.613","article-title":"Metabolic acidosis and fatal myocardial failure after propofol infusion in children: five case reports","volume":"305","author":"Parke","year":"1992","journal-title":"BMJ"},{"key":"10.1016\/j.neurol.2008.12.003_bib44","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1212\/01.WNL.0000032253.88378.D7","article-title":"High-dose thiopental in the treatment of refractory status epilepticus in intensive care unit","volume":"59","author":"Parviainen","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2008.12.003_bib45","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1007\/s00134-006-0154-1","article-title":"Propofol in the treatment of refractory status epilepticus","volume":"32","author":"Parviainen","year":"2006","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.neurol.2008.12.003_bib46","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1046\/j.1528-1157.2001.27500.x","article-title":"Propofol and midazolam in the treatment of refractory status epilepticus","volume":"42","author":"Prasad","year":"2001","journal-title":"Epilepsia"},{"key":"10.1016\/j.neurol.2008.12.003_bib47","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1385\/NCC:4:1:035","article-title":"Literature review, case report and expert discussion of prolonged refractory status epilepticus","volume":"4","author":"Robakis","year":"2006","journal-title":"Neurocrit Care"},{"key":"10.1016\/j.neurol.2008.12.003_bib48","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/nrn1430","article-title":"The neurobiology of antiepileptic drugs","volume":"5","author":"Rogawski","year":"2004","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.neurol.2008.12.003_bib49","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.yebeh.2006.01.006","article-title":"Determinants of success in the use of oral levetiracetam in status epilepticus","volume":"8","author":"Rossetti","year":"2006","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.neurol.2008.12.003_bib50","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1001\/archneur.62.11.1698","article-title":"Refractory status epilepticus: effect of treatment aggressiveness on prognosis","volume":"62","author":"Rossetti","year":"2005","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neurol.2008.12.003_bib51","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1212\/01.wnl.0000223352.71621.97","article-title":"A clinical score for prognosis of status epilepticus in adults","volume":"66","author":"Rossetti","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2008.12.003_bib52","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1111\/j.0013-9580.2004.01904.x","article-title":"Propofol treatment of refractory status epilepticus: a study of 31 episodes","volume":"45","author":"Rossetti","year":"2004","journal-title":"Epilepsia"},{"key":"10.1016\/j.neurol.2008.12.003_bib53","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.yebeh.2008.01.004","article-title":"Intravenous levetiracetam: treatment experience with the first 50 critically ill patients","volume":"12","author":"Ruegg","year":"2008","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.neurol.2008.12.003_bib54","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s11940-003-0001-4","article-title":"Diagnosis and treatment of nonconvulsive status epilepticus in an intensive care unit setting","volume":"5","author":"Ruegg","year":"2003","journal-title":"Curr Treat Options Neurol"},{"key":"10.1016\/j.neurol.2008.12.003_bib55","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1212\/WNL.51.6.1765","article-title":"Refractory status epilepticus: response to ketamine","volume":"51","author":"Sheth","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2008.12.003_bib56","doi-asserted-by":"crossref","first-page":"I122","DOI":"10.1136\/jnnp.70.suppl_2.ii22","article-title":"The management of status epilepticus","volume":"70","author":"Shorvon","year":"2001","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurol.2008.12.003_bib57","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1528-1157.1998.tb01269.x","article-title":"Treatment of refractory status epilepticus with propofol: clinical and pharmacokinetic findings","volume":"39","author":"Stecker","year":"1998","journal-title":"Epilepsia"},{"key":"10.1016\/j.neurol.2008.12.003_bib58","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1212\/01.WNL.0000042783.86439.27","article-title":"The use of topiramate in refractory status epilepticus","volume":"60","author":"Towne","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2008.12.003_bib59","series-title":"Epilepsy problem solving in clinical practice","first-page":"253","article-title":"Effective treatment for status epilepticus","author":"Treiman","year":"2000"},{"key":"10.1016\/j.neurol.2008.12.003_bib60","first-page":"243","article-title":"Treatment of status epilepticus if first drug fails","volume":"40","author":"Treiman","year":"1999","journal-title":"Epilepsia"},{"key":"10.1016\/j.neurol.2008.12.003_bib61","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1056\/NEJM199809173391202","article-title":"A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group","volume":"339","author":"Treiman","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.neurol.2008.12.003_bib62","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S1525-5050(02)00643-1","article-title":"Ketamine for refractory status epilepticus: a case of possible ketamine-induced neurotoxicity","volume":"4","author":"Ubogu","year":"2003","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.neurol.2008.12.003_bib63","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1528-1157.1990.tb05361.x","article-title":"Pentobarbital and EEG burst\u2013suppression in treatment of status epilepticus refractory to benzodiazepines and phenytoin","volume":"31","author":"Van Ness","year":"1990","journal-title":"Epilepsia"},{"key":"10.1016\/j.neurol.2008.12.003_bib64","first-page":"117","article-title":"Standards of care for non-convulsive status epilepticus: Belgian consensus recommendations","volume":"106","author":"van Rijckevorsel","year":"2006","journal-title":"Acta Neurol Belg"},{"key":"10.1016\/j.neurol.2008.12.003_bib65","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1007\/s00134-003-1905-x","article-title":"The pathophysiology of propofol infusion syndrome: a simple name for a complex syndrome","volume":"29","author":"Vasile","year":"2003","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.neurol.2008.12.003_bib66","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1212\/WNL.58.9.1327","article-title":"Seizure-like phenomena and propofol: a systematic review","volume":"58","author":"Walder","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2008.12.003_bib67","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0952-8180(94)90058-2","article-title":"Clinical pharmacokinetics of propofol given as a constant-rate infusion and in combination with epidural blockade","volume":"6","author":"Wessen","year":"1994","journal-title":"J Clin Anesth"},{"key":"10.1016\/j.neurol.2008.12.003_bib68","series-title":"The clinical practice of critical care neurology","first-page":"389","article-title":"Status epilepticus","author":"Wijdicks","year":"2003"},{"key":"10.1016\/j.neurol.2008.12.003_bib69","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/BF03028305","article-title":"Midazolam premedication reduces propofol dose requirements for multiple anesthetic endpoints","volume":"48","author":"Wilder-Smith","year":"2001","journal-title":"Can J Anaesth"},{"key":"10.1016\/j.neurol.2008.12.003_bib70","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1001\/jama.1993.03510070076040","article-title":"Treatment of convulsive status epilepticus. Recommendations of the Epilepsy Foundation of America's","volume":"270","author":"Working Group on Status Epilepticus","year":"1993","journal-title":"JAMA"},{"key":"10.1016\/j.neurol.2008.12.003_bib71","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1001\/archneur.55.1.117","article-title":"Do nonconvulsive seizures damage the brain?\u2013Yes","volume":"55","author":"Young","year":"1998","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neurol.2008.12.003_bib72","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1111\/j.1528-1167.2007.01042.x","article-title":"Propofol-associated fatal myocardial failure and rhabdomyolysis in an adult with status epilepticus","volume":"48","author":"Zarovnaya","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.neurol.2008.12.003_bib73","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1097\/00003246-200104000-00026","article-title":"Intravenous anesthetics differentially reduce neurotransmission damage caused by oxygen-glucose deprivation in rat hippocampal slices in correlation with N-methyl-D-aspartate receptor inhibition","volume":"29","author":"Zhan","year":"2001","journal-title":"Crit Care Med"}],"container-title":["Revue Neurologique"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378709000691?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378709000691?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,21]],"date-time":"2018-12-21T07:20:10Z","timestamp":1545376810000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0035378709000691"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4]]},"references-count":73,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["S0035378709000691"],"URL":"https:\/\/doi.org\/10.1016\/j.neurol.2008.12.003","relation":{},"ISSN":["0035-3787"],"issn-type":[{"value":"0035-3787","type":"print"}],"subject":[],"published":{"date-parts":[[2009,4]]}}}